{"filings":[{"id":2135196,"accession_number":"0001656472-26-000053","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K/A","filed_at":"2026-08-07T21:03:20+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group board adopts annual Say-on-Pay votes after shareholder preference","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["At June 18, 2026 annual meeting, shareholders preferred annual Say-on-Pay votes.","Board determined future Say-on-Pay votes will be held annually until next required vote.","Decision aligns with board's recommendation in proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2088320,"accession_number":"0001656472-26-000050","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2026-08-06T11:31:58+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q2 net revenue up 58% YoY to $53M; record Adjusted EBITDA of $13.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $53.0M (+58% YoY); organic constant-currency growth 51%.","Net income $35.7M vs loss of $38.5M in Q2 2025; Adjusted EBITDA $13.1M (up 675%).","Record net revenue in Canada, Israel (10th consecutive quarter), and international ex-Israel.","Repurchased 12.3 million shares in H1 2026; pending CanAdelaar acquisition expected H2 2026.","New Israeli anti-dumping investigation initiated Aug 5, 2026; Company disputes allegations."],"consensus_eps_estimate":null,"consensus_eps_actual":0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":98217000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1197036,"accession_number":"0001656472-26-000039","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2026-06-22T21:04:19+00:00","items":["5.07"],"status":"ready","headline":"Cronos shareholders elect all 7 director nominees, approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 7 director nominees elected with >207M votes for each; Michael Gorenstein received 207.8M for, 14M withheld.","Say-on-pay advisory resolution approved: 219.8M for, 1.6M against, 395K abstained.","Shareholders chose one-year frequency for future say-on-pay votes (207.9M votes for 1 year).","Davidson & Company LLP ratified as independent auditor for FY2026 with 268.5M votes for, 3.3M withheld."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94472,"accession_number":"0001656472-26-000032","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2026-05-11T23:59:59+00:00","items":["1.01","2.02","8.01","9.01"],"status":"ready","headline":"Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $45.2M (+40% YoY); net income $15.7M (+103%); adjusted EBITDA $5.1M (+122%).","Spinach brand reached #1 in Canadian vapes (9.8% share); PEACE NATURALS #1 in Israel with 53% revenue growth.","Board authorized $50M share repurchase program effective May 14, 2026 through May 13, 2027.","CanAdelaar acquisition long-stop date extended from June 9 to September 9, 2026 pending Dutch regulatory clearance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":45210000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":106872,"accession_number":"0001656472-26-000015","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 2025 net revenue $44.5M (+47% YoY); net loss $0.5M vs income $43.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $44.5M, up 47% YoY; full-year net revenue $146.6M, up 25% YoY.","Q4 net loss $0.5M vs net income $43.9M in Q4 2024; Adjusted EBITDA improved to $0.5M from -$7.2M.","Full-year adjusted EBITDA $10.1M vs -$34.9M in 2024; gross margin improved to 43% from 21%.","Pending acquisition of CanAdelaar B.V. for €57.5M cash (~$67M) plus contingent earnout; expected close H1 2026.","Jared Kenost appointed Principal Accounting Officer and VP, Controller effective Feb 24, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":146587000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123198,"accession_number":"0001656472-25-000118","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Cronos to acquire CanAdelaar, Dutch cannabis market leader, for US$67M upfront plus earnouts","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Upfront consideration of €57.5M (US$67.0M) cash, plus earnout of 0.5x normalized EBITDA in 2026 and 2027.","CanAdelaar is the largest cannabis company in the Netherlands' adult-use pilot program (Wietexperiment), one of ten licensed growers.","Upfront consideration represents ~1.4x LTM revenue and ~2.4x LTM EBITDA (unaudited, Dutch GAAP, 12 months ended Sep 30, 2025).","Transaction expected to close in H1 2026, subject to regulatory approvals including Dutch Minister of Health and Bibob screening.","Acquisition unanimously approved by Cronos board; deal establishes footprint in Europe's largest adult-use cannabis market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123197,"accession_number":"0001656472-25-000100","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q3 net revenue $36.3M (+6% YoY); record Adj. EBITDA of $5.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $36.3M, up 6% YoY; gross profit $18.3M (50% margin) vs $3.6M (11%) a year ago.","Net income $28.3M vs $7.3M YoY; Adjusted EBITDA $5.7M vs ($6.0M) in Q3 2024.","Record net revenue in Israel; PEACE NATURALS #1 brand; Spinach #2 brand in Canada.","Cronos GrowCo expansion complete, sales commenced Fall 2025; cash $824M, debt-free.","International ex-Israel shipments shifted to Q4; H2 revenue expected in line with H1."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":102056000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139864,"accession_number":"0001656472-25-000083","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cronos terminates VP Controller Lloyd Wilson for cause effective Aug 29, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lloyd Wilson terminated as VP, Controller and Principal Accounting Officer for cause, effective immediately.","Company states termination is unrelated to financial results, operations, or internal controls.","No disagreements regarding the company's financial or reporting practices were cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":139863,"accession_number":"0001656472-25-000077","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Cronos Q2 net revenue $33.5M (+21% YoY); adjusted EBITDA turns positive to $1.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $33.5M, up 21% YoY; adjusted gross margin improved to 43% from 23%.","Adjusted EBITDA of $1.7M vs -$11.1M a year ago; net loss widened to $38.5M on FX loss.","Record international and Israel revenue; PEACE NATURALS #1 cannabis brand in Israel.","Cronos GrowCo expansion complete; sales expected in fall 2025; anti-dumping duty vetoed in Israel.","Appointed Lloyd Wilson as principal accounting officer, replacing James McGinness."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":65717000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157457,"accession_number":"0001656472-25-000067","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group 2025 annual meeting: all director nominees elected, say-on-pay and auditor ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Seven director nominees elected with over 206M votes for each; broker non-votes ~53.8M.","Advisory vote on executive compensation passed with 210.1M for, 12.6M against, 0.5M abstain.","Davidson & Company LLP ratified as auditor for FY2025 with 273.0M for, 3.95M withhold."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157456,"accession_number":"0001656472-25-000057","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Cronos Q1 net revenue $32.3M (+28% YoY), net income $7.7M; authorizes $50M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $32.3M (+28% YoY); net income $7.7M vs loss of $2.5M in Q1 2024.","Adjusted EBITDA $2.3M vs -$10.7M; adjusted gross margin 44% vs 18%.","Board authorized $50M share repurchase program; opens May 14, 2025, up to 19.3M shares.","PEACE NATURALS #1 cannabis brand in Israel; Spinach #2 brand in Canada with 4.6% share.","Cronos GrowCo cultivation expansion on track for Q2 completion; first sales H2 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":32262000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175828,"accession_number":"0001656472-25-000047","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group appoints Anna Shlimak as CFO; James Holm departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anna Shlimak appointed CFO effective March 19, 2025; James Holm ceases as CFO but remains employed through April 18, 2025.","Shlimak previously Chief Strategy Officer since Sep 2024; joined Cronos in 2018 as Head of IR.","Shlimak receives base salary $372,000, target bonus 115% of salary, one-time RSU award $157,800.","Holm receives cash severance $385,000 (one year salary), prorated bonus $104,046, and accelerated option vesting.","Holm subject to non-competition and non-solicitation covenants through April 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":175827,"accession_number":"0001656472-25-000012","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 revenue up 27% YoY to $30.3M; reports net income of $43.9M vs prior year loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $30.3M (+27% YoY); full-year revenue $117.6M (+35% YoY).","Net income of $43.9M in Q4 (vs loss of $45.2M); full-year net income $40.0M (vs loss of $70.4M).","Adjusted EBITDA improved to -$7.2M in Q4 from -$14.8M; full-year -$34.9M from -$61.6M.","Spinach #1 cannabis brand in Canada; PEACE NATURALS #1 in Israel; achieved $8.7M operating expense savings in 2024.","Cash and equivalents $858.8M; Cronos GrowCo expansion on track for Q2 2025 completion."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":117615000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":192738,"accession_number":"0001656472-24-000101","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q3 revenue up 38% to $34.3M; Spinach becomes #1 cannabis brand in Canada","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $34.3M, +38% YoY; net income $7.3M vs loss of $1.6M in Q3 2023.","Adjusted EBITDA loss improved 60% to $(6.0)M from $(15.2)M.","Spinach brand became #1 cannabis brand in Canada (Hifyre); #1 in edibles and flower categories.","Cash and cash equivalents $862M, up from $571.6M a year ago; short-term investments zero.","Cronos consolidated Cronos GrowCo; contributed $4.3M revenue; $51M facility for expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":87314000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209185,"accession_number":"0001656472-24-000088","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q2 net revenue rises 46% to $27.8M; net loss widens, Adj EBITDA improves","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $27.8M, up 46% YoY; gross profit $6.3M (+103%).","Net loss $8.8M vs $5.7M YoY; Adjusted EBITDA -$11.1M (improved from -$15.9M).","Cash and equivalents $848M; provided $51M credit facility to Cronos GrowCo for expansion.","Spinach #1 flower brand in Canada with 6.2% market share; Lord Jones #1 hash infused pre-roll.","Operating expense savings target $5-10M for 2024; net cash change no longer positive due to GrowCo investment."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":53050000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209184,"accession_number":"0001656472-24-000080","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K/A","filed_at":"2024-07-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group shareholders approve reappointment of Davidson & Company LLP as auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["On July 19, 2024, reconvened annual meeting approved auditor appointment.","Davidson & Company LLP reappointed as independent auditor for fiscal 2024.","Votes: 270,300,960 for, 3,834,201 withheld."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227080,"accession_number":"0001656472-24-000078","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Cronos ups GrowCo credit by C$70M to C$175M, secures supply rights for Phase 2","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Credit Agreement adds C$70M Term Loan B for Phase 2 cannabis facility; total facility now C$175M.","Term Loan A (C$105M) matures March 2031 at Prime+1.25%; Term Loan B matures 10 yrs after Phase 2 cultivation start.","Supply Agreement gives Cronos right to purchase 70-80% of GrowCo output at fixed prices for 4-year term.","Effective July 1, 2024, GrowCo board expands to 5 members; Cronos appoints 3, will consolidate results from Q3 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227079,"accession_number":"0001656472-24-000076","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cronos Group 2024 annual meeting results: directors elected, say-on-pay passes, auditor vote postponed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected; Michael Gorenstein received 204.4M votes for, 14.4M against.","Advisory say-on-pay resolution approved: 210.4M For, 8.0M Against, 0.3M Abstain.","Meeting adjourned to complete search for successor independent auditor; Proposal 3 not presented.","Adjournment motion passed: 216.7M For, 1.7M Against, 0.4M Abstain.","Company will disseminate details once successor auditor identified; no auditor named yet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227078,"accession_number":"0001656472-24-000071","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-05-28T23:59:59+00:00","items":["1.02","7.01","9.01"],"status":"ready","headline":"Cronos terminates sale-leaseback of Peace Naturals Campus after buyer fails condition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement terminated May 28, 2024; Future Farmco Canada did not satisfy due diligence/financing condition by May 27 deadline.","Security deposit held in trust returned to buyer per agreement terms.","Company evaluating strategic options for Peace Naturals Campus, including continuing or expanding operations.","Property is located in Stayner, Ontario at 4491 Concession 12 Sunnidale Road."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227077,"accession_number":"0001656472-24-000062","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q1 revenue up 30% YoY to $25.3M; net loss narrows; guidance reaffirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $25.3M (+30% YoY); gross profit $4.5M (+53%); net loss improved to $(2.5M) from $(18.0M).","Adjusted EBITDA of $(10.7M) improved $5.0M YoY; cash and equivalents $855M.","Spinach brand #1 flower and #3 vape in Canada; Lord Jones #1 hash infused pre-roll.","Launched PEACE NATURALS in UK via GROW Pharma partnership in May 2024.","Reiterated $5-10M operating expense savings target for 2024; expects positive net cash change."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":25288000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227076,"accession_number":"0001656472-24-000054","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cronos enters voting agreement with Altria for 2024 annual meeting support","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Altria agrees to vote its Cronos shares in favor of all company proposals at 2024 annual meeting.","Altria has rights to nominate four directors: Kamran Khan, Dominik Meier, Elizabeth Seegar, Murray Garnick.","Agreement covers proposals including director election; Altria may terminate if nominees not presented.","Voting agreement runs through earliest of Sept 26, 2024 or filing of final voting results.","Company must use best efforts to hold annual meeting by June 20, 2024; auditor proposal subject to Altria consultation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227075,"accession_number":"0001656472-24-000052","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Cronos Group auditor KPMG exits; will not seek re-appointment for 2024 audit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["KPMG notified Cronos it will not stand for re-appointment for 2024 audit due to KPMG's decision to cease auditing cannabis companies.","KPMG issued unqualified opinions on financials for 2023 and 2022, but an adverse opinion on internal controls for 2022 (material weakness).","No disagreements between company and KPMG; company will promptly initiate search for a new auditor.","KPMG will continue to review Q1 and Q2 2024 quarterly results until replaced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227074,"accession_number":"0001656472-24-000045","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-04-03T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Cronos Group appoints Adam Wagner as Head of Cronos Israel; Gorelik becomes Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ran Gorelik steps down as GM of Cronos Israel effective April 2, 2024; becomes Chairman through April 1, 2026.","Gorelik's monthly base salary reduced to NIS 45,000 (Apr 2024–Mar 2025) then NIS 30,000 (Apr 2025–Apr 2026).","Gorelik eligible for annual bonus of NIS 189,000 (2024) and NIS 90,000 (2025); equity grants of $100k (2024) and $50k (2025).","Adam Wagner, formerly VP Finance of Cronos Israel, appointed Senior Vice President, Head of Cronos Israel, overseeing operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":245994,"accession_number":"0001656472-24-000017","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 net revenue up 9% YoY; net loss improves to $45M; cash balance $862M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $23.9M (+9% YoY); full-year net revenue $87.2M (+1% YoY).","Q4 net loss $45.2M, improved from $76.2M loss in Q4 2022; full-year net loss $70.4M vs $155.2M.","Adjusted EBITDA -$14.8M in Q4, improved $4.2M YoY; full-year -$61.6M, improved $8.7M.","Ended Q4 with ~$862M cash; expects positive cash flow in 2024 on ~$40-50M interest income and $5-10M cost savings.","Spinach brand #2 in Canada; launched Lord Jones in Canada; commenced Australia sales; Israel-Hamas war hit Israel sales."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":87241000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":263449,"accession_number":"0001656472-23-000149","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-11-27T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Cronos Group enters sale-leaseback of Stayner facility for C$23M cash","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cronos subsidiary agrees to sell Peace Naturals Campus to Future Farmco Canada for C$23M.","Closing subject to Buyer's due diligence (180 days), Health Canada site perimeter approval, and lease agreement (75 days).","Expected lease term: 5 years + one 5-year renewal option; Cronos can terminate after year 2 with 12-month notice.","CEO states transaction reduces costs, improves gross margin, and strengthens balance sheet.","No expected interruption to operations; Cronos will lease back portions of facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":263448,"accession_number":"0001656472-23-000145","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q3 net revenue $24.8M (+22% YoY); net loss narrows to $1.6M from $33.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $24.8M (+22% YoY); constant currency $26.0M (+27% YoY). Grows driven by Canadian flower, extract sales.","Net loss from continuing ops $(1.6)M improves from $(33.1)M; no impairment in current period, higher interest income.","Adjusted EBITDA $(15.2)M vs $(18.5)M prior year; gross margin 16% (19% adj. for inventory write-down).","Cash & short-term investments $839.6M; guidance: net cash decline <$5-10M in Q4 2023, positive cash flow in 2024.","Spinach brand top-10 Canadian retail in all categories; launched Peace Naturals in Germany and Lord Jones in Canada."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":63326000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":280660,"accession_number":"0001656472-23-000124","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q2 revenue down 12% to $19M, withdraws FY2023 guidance; announces facility wind-down","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net revenue $19.0M (-12% YoY); net loss improved to $(5.7)M from $(17.5)M YoY.","Withdrew FY2023 net revenue target of $100-110M citing political unrest in Israel and competitive activity.","Operating expense savings target raised to $20-25M; planning wind-down of Cronos Fermentation facility by end of 2023.","Cash and short-term investments $841M; net cash decline for H2 2023 expected less than $5-10M (improved guidance).","Expects incremental $10-15M savings in 2024 from additional expense reductions and facility exit."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":38516000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299295,"accession_number":"0001656472-23-000106","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-06-23T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cronos Group shareholders elect all seven directors, approve say-on-pay and auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Each director nominee elected with >94.8% support; Kamran Khan lowest at 94.81%.","Advisory say-on-pay resolution passed with 92.71% of votes cast in favor.","KPMG LLP reappointed as independent auditor for 2023 with 99.12% votes for.","Voter turnout 64.96% of outstanding shares (247,410,987 shares voted).","No changes to board composition or executive compensation structure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299294,"accession_number":"0001656472-23-000099","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cronos Group to exit U.S. hemp CBD ops, raise savings target to $20-25M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Will wind down U.S. hemp-derived CBD operations by end of Q2 2023; expects up to $1.8M in exit costs.","Increases 2023 operating expense savings target to $20-$25M from prior $10-$20M.","Plans to launch Lord Jones brand in Canadian adult-use market in Q4 2023.","Held $836M cash and short-term investments with zero debt as of March 31, 2023.","Will report as one consolidated segment starting Q2 2023, discontinuing U.S. and Rest of World segments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299293,"accession_number":"0001656472-23-000081","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cronos Group appoints James McGinness as VP, Controller and principal accounting officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James McGinness appointed VP, Controller and principal accounting officer effective May 22, 2023.","Carlos Cortez will cease as principal accounting officer on May 22, 2023 and separate from company on June 16, 2023.","McGinness previously Acting CFO and VP Corporate Controller at MarketWise; background includes public company finance roles.","McGinness receives $250k base salary, 30% target annual bonus, and 30% long-term target incentive."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299292,"accession_number":"0001656472-23-000065","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q1 revenue $20.1M (-20% YoY); gross margin 12%; targets cash flow positive 2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $20.1M, down 20% YoY; gross margin 12% vs 28%; net loss $(19.3)M improved from $(32.7)M.","Canada net revenue +6% YoY (constant currency +14%); Spinach® top-10 in flower, edible, vape, pre-roll.","Cash & short-term investments $836M; no debt; targeting positive cash flow in 2024.","FY2023 revenue guidance $100-110M; expects ~$30M interest income for remainder of year; on track for $10-20M cost savings."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":20144000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319448,"accession_number":"0001656472-23-000014","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group FY2022 revenue $91.9M (+23% YoY); net loss narrows to $168.7M; Spinach #1 edible brand in Canada","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2022 net revenue $91.9M, up 23% YoY; Israel revenue up 128% (constant currency +137%).","Q4 2022 net revenue $22.9M, down 11% YoY; gross profit -$0.2M vs $1.9M in Q4 2021.","Full-year net loss $168.7M, improved from $397.2M; Adjusted EBITDA -$80.6M, improved from -$160.5M.","Achieved $28.7M in operating expense savings in 2022; targeting additional $10-20M savings in 2023.","Spinach became #1 edible brand in Canada in Jan 2023; appointed James Holm as CFO in Nov 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":91904000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319447,"accession_number":"0001656472-23-000008","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K/A","filed_at":"2023-02-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group finalizes CFO Robert Madore's separation terms; $450k lump sum, accelerated equity vesting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lump sum payment of $450,000 (one year salary) plus $18,356.61 for benefits premium.","Pro-rated 2022 bonus: individual performance component $123,750, business component per STIC Program formula.","Accelerated vesting of 450,000 stock options and 37,500 RSUs; options exercisable until June 14, 2023.","Ongoing non-disparagement, confidentiality, and non-competition covenants reaffirmed in separation agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":337649,"accession_number":"0001656472-22-000201","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-12-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Altria relinquishes warrant to buy 84.2M Cronos shares at C$19 for no consideration","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Altria abandoned warrant for up to 84,243,223 Cronos common shares at C$19.00 per share, effective Dec 16, 2022, for no consideration.","Altria continues to hold 156,573,537 Cronos common shares (beneficial ownership) and retains four board designees.","The warrant's relinquishment eliminates potential dilution of ~84M shares but does not affect Altria's existing rights under Investor Rights Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":337648,"accession_number":"0001656472-22-000170","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group names James Holm as CFO effective Nov 14, 2022; Robert Madore departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Madore ceased as CFO; receives one-year base salary severance, pro-rated bonus, and accelerated vesting of 37,500 RSUs and 450,000 options.","James Holm appointed CFO, effective Nov 14, 2022; previously Global VP of Finance Transformation at Vertiv.","Holm's compensation: $385,000 base salary, 115% target bonus, $250,000 signing bonus, and one-time equity (options $250k, RSUs $50k).","Holm eligible for annual long-term incentive target of $577,500 starting in FY2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":337647,"accession_number":"0001656472-22-000161","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q3 revenue up 3% to $20.9M; net loss $36.9M vs prior year income; Jeff Jacobson named CGO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Consolidated net revenue $20.9M, up 3% YoY; constant currency +7% to $21.8M.","Net loss $36.9M driven by non-cash derivative revaluation; prior year net income $77.7M.","Adjusted EBITDA improved to -$21.7M from -$46.8M YoY; on track for $20-25M cost savings.","Israel net revenue up 88% to $7.0M; constant currency +98%.","Appointed Jeff Jacobson as Chief Growth Officer; launched Spinach infused pre-rolls."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":69017000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":337646,"accession_number":"0001656472-22-000146","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-10-25T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cronos settles SEC and OSC investigations over accounting errors; pays C$1.34M, loses WKSI status","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["SEC order imposes cease-and-desist; no monetary penalty but Cronos loses WKSI status for 3 years and Regulation A/D exemption use for 5 years.","OSC settlement requires C$1.34M payment; Cronos acknowledged non-compliance with Ontario Securities Act reporting requirements.","Both settlements resolve improper revenue recognition ($5.8M overstated in 2019) and delayed impairment charge of $234.9M in 2021.","Cronos agrees to retain independent consultant to review internal accounting controls under both settlements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":337645,"accession_number":"0001656472-22-000139","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-10-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group SVP John Griese departs; Jeff Jacobson assumes North American operations","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Griese no longer serves as SVP, Head of Operations (North America) effective Oct 18, 2022.","Jeff Jacobson, SVP Head of Growth (North America), takes over operations oversight.","Jacobson previously served as GM of Canada and Europe; joined Cronos in Dec 2016; co-founded Peace Naturals.","No reason provided for Griese's departure; no external replacement named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355020,"accession_number":"0001656472-22-000111","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q2 net revenue $23.1M (+48% YoY); net loss narrows to $20.3M from $179.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Consolidated net revenue $23.1M, up 48% YoY; Rest of World segment $21.6M (+61%); U.S. $1.5M (-34%).","Net loss $20.3M improved from $179.4M; Adjusted EBITDA -$18.8M vs -$49.8M a year earlier.","Gross profit $4.1M (gross margin 18%) vs -$15.8M (-101%) in Q2 2021; no inventory write-downs this quarter.","Realignment costs now expected at ~$6.4M (up from $5.8M); phased exit of U.S. wholesale beauty channel.","Arye Weigensberg appointed SVP Head of R&D; THCV productivity milestone achieved under Ginkgo partnership."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":48094000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373080,"accession_number":"0001656472-22-000104","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-06-24T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cronos Group announces 2022 Annual Meeting results; all directors elected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with >91.6% votes each; Jason Adler 92.14%, James Rudyk 91.63%.","Advisory say-on-pay resolution approved with 95.02% of votes cast in favor.","KPMG LLP re-appointed as independent auditors for fiscal year ending December 31, 2022.","Turnout: 265,763,587 shares voted (70.76% of outstanding)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373079,"accession_number":"0001656472-22-000092","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Q1 revenue up 99% YoY to $25M; net loss narrows; Gorenstein returns as CEO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Consolidated net revenue $25.0M (+99% YoY); Israel net revenue $9.1M (+263% YoY).","Gross profit $6.9M (28% margin) vs -$3.0M in Q1 2021; net loss $32.7M vs $161.6M.","Adjusted EBITDA loss improved to $(18.9)M from $(36.6)M; cost savings target $20-25M in 2022.","Spinach brand held ~13% edible market share in Canada; gummy share ~17% in Q1 2022.","Founder Mike Gorenstein appointed Chairman, President and CEO in March 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":25033000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":391859,"accession_number":"0001656472-22-000065","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-03-21T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Cronos Group founder Mike Gorenstein returns as CEO, replaces retiring Kurt Schmidt","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gorenstein appointed President and CEO effective March 21, 2022; continues as Chairman.","Kurt Schmidt retired as President and CEO, will assist transition through April 6, 2022.","Gorenstein receives $775k base salary, 150% target bonus, and 3M RSUs vesting in 3 years.","Gorenstein's prior-year bonuses contingent on conclusion of SEC investigation without penalty.","Schmidt gets $520k lump sum plus benefits; $675k bonus tied to SEC investigation outcome."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":391858,"accession_number":"0001656472-22-000033","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-03-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q4 revenue $25.8M (+51% YoY), net loss $133.9M; plans Stayner facility exit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $25.8M in Q4 (+51% YoY); full-year revenue $74.4M (+59% YoY).","Q4 net loss $133.9M (incl. $119.9M impairment); full-year net loss $397.2M.","Announced planned exit of Peace Naturals Campus in Stayner, Ontario by end of 2022.","Adjusted EBITDA improved to -$27.4M in Q4 (vs -$53.1M) but full-year -$160.5M (worse).","Cash and equivalents $886.9M as of Dec 31, 2021, down 18% from year-end 2020."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":74435000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":391857,"accession_number":"0001656472-22-000020","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-02-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos restates Q2 2021 with $236M impairment; Q3 rev up 80% to $20.4M, adj EBITDA loss widens","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Restated Q2 2021 with $236.1M impairment on goodwill and intangibles in U.S. reporting unit; no cash impact.","Q3 2021 net revenue $20.4M (+80% YoY); gross profit improved to $(0.7)M from $(1.5)M.","Adjusted EBITDA loss $(46.8)M vs $(30.1)M; driven by $13.2M allowance for credit losses and higher R&D.","Strategic realignment targets $20-25M in operating expense savings in 2022.","Announced key appointments: Jeff Jacobson SVP Head of Growth and John Griese SVP Head of Operations (North America)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":74435000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":391856,"accession_number":"0001656472-22-000003","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2022-01-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group appoints John Griese as SVP, Head of Operations (North America)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Griese promoted to SVP, Head of Operations (North America) effective Jan 10, 2022.","Mr. Griese joined Cronos in August 2021 as VP of Operations; previously COO of Supreme Cannabis and Creso Pharma.","He will oversee North American operations for Cronos Group.","No other changes to executive team disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410133,"accession_number":"0001656472-21-000131","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2021-11-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cronos Group EVP & Corporate Secretary Xiuming Shum resigns effective Nov 30, 2021","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Xiuming Shum resigns as EVP, Legal & Regulatory Affairs and Corporate Secretary effective Nov 30, 2021.","Entitled to CAD $343,750 prorated 2021 annual bonus (target performance) and continued vesting of equity awards.","Will provide consulting services Dec 1-31, 2021 at USD $31,250/month; up to 20 hours/week.","Non-disparagement and post-employment restrictive covenants (non-competition, non-solicitation, confidentiality) reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410132,"accession_number":"0001656472-21-000127","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2021-11-23T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Cronos Group receives Nasdaq delinquency notice for late Q3 10-Q; MCTO issued","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notice, dated Nov 16, 2021, cites non-compliance with Listing Rule 5250(c)(1) for untimely Form 10-Q.","Notice has no immediate impact on CRON common stock listing or trading on Nasdaq.","Canadian securities regulators issued a management cease trade order (MCTO) on Nov 16, restricting trading by CEO and CFO.","MCTO remains until two full business days after filing the overdue Q3 2021 10-Q.","Cronos confirms no material change to prior disclosure and continues working to complete required filings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410131,"accession_number":"0001656472-21-000120","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2021-11-09T23:59:59+00:00","items":["4.02","9.01"],"status":"ready","headline":"Cronos to restate Q2 2021 financials; at least $220M impairment in U.S. reporting unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Previously issued unaudited interim financial statements for Q2 2021 should no longer be relied upon.","Impairment charge of not less than $220M on goodwill and indefinite-lived intangible assets in U.S. reporting unit.","Triggering events reassessed as of June 30, 2021; impairment should have been recorded in Q2 2021.","No other changes are anticipated beyond the impairment charge.","Company evaluating whether to record an additional impairment in Q3 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410130,"accession_number":"0001656472-21-000112","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2021-10-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Dr. Todd Abraham retires as Cronos Group Chief Innovation Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Todd Abraham retired as Chief Innovation Officer, effective October 29, 2021.","Company is conducting a search for his successor.","Arye Weigensberg appointed interim Head of Research and Development."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":428980,"accession_number":"0001656472-21-000090","cik":1656472,"company_name":"Cronos Group Inc.","ticker":"CRON","form_type":"8-K","filed_at":"2021-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Cronos Group Q2 net revenue $15.6M (+58% YoY); gross loss expands to $15.8M; invests $110M in PharmaCann","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $15.6M, up 58% YoY; ROW segment $13.4M (+74%) driven by Canada adult-use and Israel medical.","Gross loss $15.8M (from $2.9M loss); inventory write-downs $12M; Adj EBITDA loss $49.8M.","Strategic investment: option to acquire ~10.5% stake in PharmaCann for ~$110.4M, with commercial agreements.","Amended Ginkgo Bioworks agreement; commenced commercial-scale CBG production in June 2021.","Appointed Kendrick Ashton Jr. to Board; new Head of Regulatory, Global Head of Audit, VP Controller."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":28233000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1401232567.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2021-08-06T23:59:59+00:00|428980"}